Background: Release of membrane proteins from the cell surface by the metalloproteinase ADAM10 is post-translationally regulated. Results: The cytoplasmic domain of ADAM10 negatively controls its constitutive activity but is dispensable for its stimulation. Conclusion: Post-translational stimulation of ADAM10 requires its transmembrane and/or extracellular domain. Significance: Elucidating the regulation of ADAM10 is crucial for understanding the control of ADAM10-dependent cell surface proteolysis.
The cell surface metalloproteinase ADAM10 (a disintegrin and metalloprotease 10) is required for the proteolytic release of membrane proteins such as the EGF (1), betacellulin (BTC) 4 (1, 2), the amyloid precursor protein (3), and the low affinity IgE receptor CD23 from cells (4) , and it also has a critical function in regulating physiological ligand-induced Notch signaling (5) (6) (7) . ADAM10 is constitutively active in cell-based assays that measure ADAM10-dependent substrate release (1) , and its activity can be rapidly up-regulated by treatment of cells with the calcium ionophore ionomycin and by activation of the P2X7 receptor (8, 9) . ADAM10 is closely related to the protein ectodomain sheddase ADAM17 (also referred to as the TNF␣ convertase, or TACE), which can also be rapidly activated by several different stimuli (1, 8, 9) . The rapid activation of ADAM17 does not require its cytoplasmic domain and is not regulated by removal of its inhibitory prodomain by proprotein convertases (8, 10) but instead depends on the presence of its transmembrane domain (11) . Little is currently known about the domains of ADAM10 that are important for its constitutive activity or rapid post-translational activation. The goal of the current study was to learn more about the post-translational regulation of ADAM10 and to determine what role, if any, the cytoplasmic and the transmembrane domains of ADAM10 have in the constitutive and regulated shedding of its substrates. In addition, we explored whether prodomain removal by proprotein convertases, as well as influx of calcium or other ions, is important for the stimulation of ADAM10-dependent shedding.
EXPERIMENTAL PROCEDURES
Cell Lines and Reagents-Embryonic fibroblasts from Adam10/17 Ϫ/Ϫ mice (mEF) were described previously (9) . Cos7 cells were from ATCC (Manassas, VA). Cells were grown in DMEM with antibiotics and 10% FCS. All reagents were from Sigma-Aldrich unless otherwise indicated. The proprotein convertase inhibitor decanoyl-RVKR-CMK (RVKR), the chloride channel inhibitor di-phenylamine-2-carboxylate, and ionomycin (IO) were from Calbiochem; monoclonal mouse anti-HA antibodies were from Covance (Emeryville, CA). Marimastat was a gift from Ouathek Ouerfelli (Sloan-Kettering Institute, New York, NY).
Expression Vectors-Expression vectors for WT mouse ADAM10, the catalytically inactive mouse ADAM9E3A (A9E3A), the human P2X7R, and alkaline phosphatase (AP)-tagged substrate proteins human BTC, human TGF␣, and human CD62L were described previously (1, 4, 8, 9) . The mouse ADAM10⌬cyto mutant and the chimera between mouse ADAM10 and mouse ADAM17 were generated by fusion PCRs with murine ADAM10 and ADAM17 cDNAs as a template (see Table 1 for the sequences of the chimera and other mutants used in this study) (8) .
Cell Culture, Transfection, and Ectodomain Shedding Assays-Cells were transiently transfected with the indicated plasmids using Genjet (SignaGen, Ijamsville, MD), Turbofect (Thermo-Fisher Scientific) or Lipofectamine 2000 (Life Technologies, Inc.) with essentially identical results. Shedding assays were performed the day after transfection (1, 8, 9, 12) . For shedding experiments including inhibitors, cells were preincubated with or without inhibitors for 2-12 h, as indicated. For stimulation experiments, the cells were washed briefly three times followed by incubations with the indicated stimulus for 45 min. Constitutive shedding was measured after 2 h of incubation. In experiments in which BzATP was used to stimulate ADAM10, its receptor, the human P2X7R, was co-transfected with the ADAM10 substrate BTC-AP. Experiments to test the requirement for extracellular calcium ions were performed in minimal medium (0.814 mM MgSO 4 ⅐7H 2 O, 5.33 mM KCl, 44.05 mM NaHCO 3 , 81.9 mM NaCl, 0.9 mM NaH 2 PO 4 ⅐H 2 O, 25.03 mM Hepes) with or without added CaCl 2 (0.45 mM). AP activity in the supernatants and cell lysates was measured by colorimetry (12) . The ratio between the supernatant AP activity and the total AP activity in the cell lysate plus supernatant was calculated from three identically prepared wells and averaged. This value can be used for side by side comparisons of the activity of a given sheddase toward a given AP-tagged protein for the indicated stimulus in a specific cell type. Evaluation of AP activity in the supernatants and cell lysates by SDS-PAGE or by colorimetric assays was performed as described previously (12) .
Western Blot Analysis-Western blot analysis was performed as described (13) . Briefly, for detection of endogenous ADAM10 or transfected HA-tagged mouse ADAM10 and the mouse ADAM10/17 mutants, cells were lysed in PBS, 1% Triton X-100, 5 mM 1,10-phenantroline, protease inhibitor mixture (14) . The lysates were separated by SDS-PAGE and transferred to nitrocellulose membranes (13) , which were probed with the appropriate antibodies as indicated. Equal sample loading was confirmed by Ponceau S staining of the nitrocellulose membrane after transfer.
Cell Surface Biotinylation-For surface biotinylation experiments, cells were washed twice in ice-cold PBS and then incubated in PBS with 1 mg/ml of the non-membrane-permeable biotinylation reagent NHS-LC-Biotin (Pierce) for 45 min at 4°C. To stop the biotinylation reaction, the cells were washed twice in ice-cold PBS, 50 mM glycine and then incubated in PBS, 50 mM glycine for 10 min. Following lysis in PBS, 1% Triton X-100, 5 mM 1,10-phenantroline, protease inhibitor mixture (14) , the cell surface-biotinylated molecules were bound to streptavidin beads, which were washed three times in cell lysis buffer and then boiled in SDS sample buffer to remove bound proteins. The eluted proteins were separated by SDS-PAGE and transferred to nitrocellulose membranes, and the biotinylated ADAM10 WT or ADAM10⌬cyto were detected with antibodies against their C-terminal HA tag.
In-gel Alkaline Phosphatase Assay-The in-gel detection of alkaline phosphatase-labeled membrane proteins was performed as previously described (12, 15) . Briefly, lysates of cells expressing AP-tagged human BTC were separated by SDS-PAGE, and the AP was renatured by incubating the gel twice for 30 min in 2.5% Triton X-100 and visualized by adding the AP substrates nitro blue tetrazolium and 5-bromo-4-chloro-3Јindolyphosphate.
Quantitative Real Time PCR-RNA was isolated with the SV total RNA isolation kit (Promega, Madison, WI) and reverse transcribed using PrimeScript TM RT Master Mix (TaKaRa, Mountain View, CA) according to the manufacturer's protocols. Quantitative real time PCR was performed in a StepOnePlus real time PCR instrument (Applied Biosystems, Grand Island, NY). The reaction mixture consisted of 10 ng of cDNA, 0.25 M of each ADAM10 primer (CGCACAACTCTGGCTGAAAG and CCG-GAGAAGTCTGTAGTCTG), and 5 l of SYBR Premix Ex TaqII Master Mix (TaKaRa) per 10 l of mixture.
Statistical Analysis-All data are representative of at least three separate experiments. Statistical analyses were performed using an unpaired two-tailed Student's t test, with p Ͻ 0.05 considered statistically significant (indicated by an asterisk). In Fig.  7A , nonparametric two-way analysis of variance was performed along with Tukey's multiple comparison post hoc tests to assess statistical significance with a 95% confidence interval. All calculations were performed using SigmaSTAT 3.1 software.
RESULTS
The Cytoplasmic Domain of ADAM10 Exerts a Negative Control on Its Constitutive Activity-To learn about the role of the cytoplasmic domain of ADAM10 in regulating its shedding activities, we transfected Adam10/17 Ϫ/Ϫ mEFs with the ADAM10 substrate BTC together with either wild type ADAM10 (ADAM10 WT, A10 WT) or ADAM10 lacking its cytoplasmic domain (ADAM10⌬cyto, A10⌬cyto). The catalytically inactive ADAM9E3 A (A9E3 A) mutant was used as a negative control instead of ADAM10E3 A, because the latter is known to have dominant negative properties (16 -19) . The use of Adam10/17 Ϫ/Ϫ double knock-out cells transfected with ADAM10 in these experiments ensured that the BTC shedding was dependent on ADAM10 (9), whereas co-transfection with the inactive ADAM9E3 A mutant allowed us to determine baseline shedding levels for BTC in these cells in the presence of an overexpressed membrane protein of similar domain structure as ADAM10. When we analyzed the levels of membraneanchored alkaline phosphatase-tagged BTC (BTC-AP) in Adam10/17 Ϫ/Ϫ cells by using an in-gel alkaline phosphatase detection assay (see "Experimental Procedures" for details), we found significantly lower levels of BTC-AP in the lysates of cells that were co-transfected with ADAM10 WT or ADAM10⌬cyto compared with cells expressing the inactive ADAM9E3 A. Prolonged incubation of transfected cells (12 h) with 5 M of the hydroxamate-type metalloprotease inhibitor marimastat (MM) resulted in similar levels of BTC-AP in all samples. This suggested that the decrease in BTC-AP in the ADAM10 and ADAM10⌬cyto-transfected cells was caused by the catalytic activity of the overexpressed enzymes ( Fig. 1A , with quantification shown in B). Thus, both ADAM10 WT and ADAM10⌬cyto appear to have significant constitutive activity, enough to reduce the levels of BTC-AP compared with cells transfected with the inactive ADAM9E3 A.
Next we analyzed how the cytoplasmic domain of ADAM10 affected the constitutive shedding of BTC-AP into the supernatant. For this purpose, we pretreated Adam10/17 Ϫ/Ϫ mEFs expressing BTC-AP together with ADAM9E3 A, ADAM10 WT, or ADAM10⌬cyto with 5 M MM for 12 h to prevent substrate depletion by the active forms of ADAM10 and then rapidly washed the inhibitor out to initiate constitutive shedding for 2 h. Under these conditions, which ensured that the FIGURE 1. The cytoplasmic domain of ADAM10 is a negative regulator of constitutive shedding. A, mouse embryonic fibroblasts lacking ADAMs10 and 17 (Adam10/17 Ϫ/Ϫ mEFs) were transfected with BTC-AP together with the inactive ADAM9E3 A mutant (A9E3 A), wild type ADAM10 (A10 WT), or ADAM10 lacking its cytoplasmic domain (A10⌬cyto). An in-gel AP assay was used to visualize the levels of membrane-anchored BTC-AP in the cell lysates of cells incubated with or without the hydroxamate-type metalloprotease inhibitor MM (5 M) for 12 h, as indicated. The figure is representative of three experiments. B, densitometric quantification of the results of all three experiments. C, Adam10/17 Ϫ/Ϫ mEFs transfected with BTC-AP were preincubated with or without MM (5 M) for 12 h. Then the cells were washed and incubated for 2 h. MM blocked the constitutive shedding in the first 12 h and could be readily washed out, resulting in increased BTC shedding from cells transfected with A10 WT or A10⌬cyto treated with MM compared with cells not incubated with MM. The top panel shows the AP activity in the conditioned medium (CM), whereas the lower panel shows the AP activity in the cell lysate (CL) (n ϭ 17; means Ϯ S.D.). D, Western blot analysis of the expression of A10 WT and A10⌬cyto in Adam10/17 Ϫ/Ϫ mEFs, using antibodies against the C-terminal HA tag of the expressed proteins. E, Western blot of the expression of ADAM9 in Adam10/17 Ϫ/Ϫ mEFs that were not transfected or were transfected with A9E3 A. F, detection of the biotinylated mature form of A10 WT or A10⌬cyto after precipitation of cell surface biotinylated materials with streptavidin-Sepharose followed by detection with antibodies against the HA tag attached to both ADAM10 constructs. The Western blots (D and E) and the detection of cell surface biotinylation (F) are representative of three experiments each (means Ϯ S.D.). *, p Ͻ 0.05, unpaired two-tailed Student's t test. Ctrl, control; MW, molecular mass; WB, Western blot. substrate levels were comparable at the outset of the experiment (as shown in the MM-treated samples in Fig. 1, A and B) , it became clear that the ADAM10⌬cyto mutant had increased catalytic activity compared with ADAM10 WT (Fig. 1C ), despite substantially lower levels of the pro-form and somewhat reduced levels of the mature form ( Fig. 1D , expression of the ADAM9E3 A mutant is shown in E). It should be noted that the ADAM10⌬cyto mutant also consumed slightly more of the substrate in the 2 h after the MM was washed out than ADAM10 WT, yet presumably sufficient amounts of substrate remained to ensure that the substrate levels were not limiting in samples pretreated with MM (Fig. 1C, lower panel) . Finally, when we performed a cell surface biotinylation, we found stronger labeling of the mature form of ADAM10⌬cyto compared with ADAM10 WT (Fig. 1F ). Taken together, these results suggest that the cytoplasmic domain of ADAM10 is a negative regulator of its ability to shed BTC-AP from cells.
The Western blot analysis of ADAM10 WT and ADAM10-⌬cyto suggested that the cytoplasmic domain of ADAM10 could affect the levels of transfected ADAM10 in mEFs, because lower levels of pro-ADAM10⌬cyto were expressed compared with the pro-ADAM10 WT, despite using identical amounts of expression plasmids for transfection experiments (Fig. 1D ). This was further corroborated by transfecting Adam10/17 Ϫ/Ϫ mEFs with different amounts of expression plasmids (0.1-1 g/well of a 6-well plate), which resulted in comparable mRNA expression of ADAM10 WT and ADAM10⌬cyto, as determined by quantitative real time PCR ( Fig. 2A) . Nevertheless, the protein expression levels of pro-ADAM10⌬cyto were lower than for pro-ADAM10 WT at all three plasmid concentrations ( Fig. 2B ), whereas the sheddase activity of ADAM10⌬cyto was higher at all three plasmid concentrations over 2 h (Fig. 2C ).
An ER Retention Motif in the Cytoplasmic Domain of ADAM10 Controls Its Constitutive Activity-Previous studies have identified an ER retention motif at position 723 in the cytoplasmic domain of ADAM10 (20) . Mutation of this motif from ADAM10 723 RRR to ADAM10 723 RAR (A10 RRR3 RAR) or its deletion through a truncation after residue 721 (ADAM10⌬721, A10⌬721) has been shown to increase transport of the mutant proteins to the cell surface (20) . Here, we demonstrate that both mutants have a similarly increased constitutive activity over 2 h as ADAM10⌬cyto ( Fig. 3 ), suggesting that the increased activity is caused by a decrease in retention of the mutant proteins in the ER, thus providing a likely explanation for their enhanced constitutive activity.
The Cytoplasmic Domain of ADAM10 Is Not Required for Stimulated Shedding-Next, we took a similar approach to determine whether the cytoplasmic domain of ADAM10 is (Fig. 4, A-D) . All four stimuli activated BTC-AP shedding in the presence of ADAM10 WT, and there was also an increase in unstimulated BTC-AP compared with ADAM9E3 A control-transfected cells (Fig. 4 , A-D). In ADAM10⌬cyto-transfected cells, there was an increase in constitutive shedding compared with ADAM10 WT-transfected cells, as described above. Moreover, the shedding in ADAM10⌬cyto-transfected cells was significantly enhanced by all four stimuli, with an approximately comparable amount of increase over constitutive shedding as seen in ADAM10 WT-transfected cells (although minor effects of the cytoplasmic domain on stimulated shedding cannot be ruled out).
Evaluation of the Role of the Transmembrane Domain of ADAM10 in Regulating Its Sheddase Activity-Because the transmembrane domain of ADAM17 is required for its response to a variety of stimuli (11), we tested whether the transmembrane domain of ADAM10 is important for its activation by IO. For this purpose, we generated chimeric constructs containing the extracellular domain of ADAM10 fused to the transmembrane and cytoplasmic domains of ADAM17 or only the transmembrane domain of ADAM17, without its cytoplasmic domain (KKTT or KKT, where K stands for Kuzbanian, an alternative name for ADAM10 (6) , and T stands for TACE, or TNF␣ convertase (21), an alternative name for ADAM17; see Table 1 and the diagram in Fig. 5A for details) .
We observed slightly increased shedding of BTC from Adam10/17 Ϫ/Ϫ mEFs co-transfected with KKTT or KKT compared with ADAM10 WT under unstimulated conditions. However, the addition of IO only stimulated BTC-AP shedding in the presence of ADAM10 WT, but not in the presence of the KKTT and KKT mutants (Fig. 5B) . A Western blot analysis confirmed comparable expression levels of the pro-and mature forms of ADAM10 WT, KKTT, and KKT (Fig. 5C , mature forms marked by arrowheads). Previous studies have shown that ADAM10 can cleave substrates that are primarily ADAM17 substrates, but only when ADAM17 is inactivated and ADAM10 is stimulated to enhance its activity (9) . Interestingly, when we co-transfected KKTT or KKT with CD62-L (L-selectin) or TGF␣, two substrates whose primary sheddase is ADAM17 (1, 9, 22) , we found a similar increase in shedding following stimulation with IO compared with ADAM10 WT (Fig. 5D) . None of the constructs tested here was able to support PMA-stimulated shedding of CD62L or TGF␣, which is a hallmark feature of ADAM17 (Fig. 5E ). Finally, KKTT and KKT promoted slightly higher levels of constitutive shedding of CD62-L and TGF␣ than ADAM10 WT (Fig. 5E ). mEFs transfected with A9E3 A, A17 WT, TTTK, TTT, TTKK, or TTK, as indicated. All conditioned supernatants were collected after 45 min of incubation (n ϭ 3; means Ϯ S.D.). D, Western blot analysis of all constructs shown in A, probed with antibodies against the C-terminal HA tag on these constructs (except A9E3 A, which is not tagged, see Fig. 1 ), representative of three experiments.
In the experiments shown in B and C, Adam10/17 Ϫ/Ϫ mEFs were preincubated with MM (5 M) for 12 h, then the MM was washed out, and 25 ng/ml PMA was added to stimulate the cells where indicated (n ϭ 3) (means Ϯ S.D.). *, p Ͻ 0.05 for increase in stimulated shedding over constitutive shedding unpaired twotailed Student's t test. MW, molecular mass; WB, Western blot. MARCH 20, 2015 • VOLUME 290 • NUMBER 12
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The Cytoplasmic Domain of ADAM10 Does Not Affect the Catalytic Activity of ADAM17 in Cell-based Assays-Next we tested whether the cytoplasmic domain of ADAM10 could negatively affect the activity of ADAM17. We found that replace-ment of the cytoplasmic domain of ADAM17 with that of ADAM10 had no detectable effect on the sheddase activity of ADAM17, just like removal of the cytoplasmic domain of ADAM17 (Fig. 6, A and B) . However, when the transmembrane domain of ADAM10 was used to replace that transmembrane domain of ADAM17, then the ability of ADAM17 to respond to PMA was lost, regardless of whether the cytoplasmic domain was present or not (Fig. 6, A and B) . None of these constructs could promote the PMA-dependent shedding of the ADAM10 substrate BTC (Fig. 6C) , even though the expression levels were approximately comparable by Western blot analysis (Fig. 6D) .
Inhibition of Proprotein Convertases Does Not Significantly Reduce the Rapid Activation of ADAM10 by Ionomycin-Next
we focused on the prodomain of ADAM10, which is removed by proprotein convertases in the secretory pathway (23) . Processing of the prodomain of ADAM10 in the secretory pathway is thought to be a prerequisite for its ability to acquire catalytic activity. To test whether proprotein convertases (PCs) are also required for the rapid response of ADAM10 to stimulation with ionomycin, we preincubated Cos7 cells expressing BTC-AP with the PC inhibitor RVKR for up to 8 h and then stimulated them for 45 min in the continued presence or absence of RVKR. There was no significant difference in the release of BTC-AP from Cos7 cells under constitutive conditions and following IO stimulation in the presence or absence of the PC inhibitor at the different time points tested, although we cannot rule out a minor decrease in the presence of the inhibitor (Fig. 7A) . Moreover, the amount of mature endogenous ADAM10 was not significantly affected by treatment with the PC inhibitor for up to 4 h but was significantly reduced after 8 h (Fig. 7B , with quantification shown in C). As a positive control for the inhibitory effect of RVKR, we expressed the recombinant ADAM17 metalloprotease and prodomain fused to an Fc protein (11) and found that prodomain removal was completely blocked in the presence of the PC inhibitor (data not shown; see also Ref. 11). 
Evaluation of the Contribution of Ion Flux across Cell
Membranes to the Activation of ADAM10 -The next point we addressed was whether stimulation of ADAM10 by IO depends entirely on influx of extracellular calcium or whether other major ions such as sodium, potassium, or chloride could be involved in this process. When Cos7 cells were incubated with different concentrations of IO, only the relatively high concentration of 2.5 M IO activated ADAM10 strongly, whereas concentrations of 1 M or lower did not (Fig. 8A ). This concentration of IO is likely to promote a strong influx of extracellular Ca 2ϩ (24) , which could also lead to a change in membrane potential and subsequent activation of cation and anion fluxes for normalization of the potential, so that secondary ion fluxes could be responsible for the stimulation of ADAM10. However, when we added the Na ϩ ionophores monensin (200 M) or nystatin (300 g/ml) or the K ϩ ionophore valinomycin (10 M; Fig. 8B ) or the Cl Ϫ ionophore I (25) (10 M; Fig. 8C ) to Cos7 cells expressing BTC-AP, we saw no activation of BTC-AP shedding. Moreover, IO-stimulated shedding of BTC-AP was not blocked by the chloride channel blocker di-phenylamine-2carboxylate (200 M; Fig. 8C ).
To determine how crucial influx of extracellular Ca 2ϩ is for all four stimuli of ADAM10 used in this study, we stimulated Cos7 cells transfected with BTC-AP with IO (2.5 M), APMA (250 M), BzATP (300 M), or NEM (600 M) in the presence or absence of Ca 2ϩ in the medium (Fig. 9 , BzATP-treated cells were co-transfected with the purinergic receptor P2X7R). We found that Ca 2ϩ was required for the stimulation of ADAM10 by IO and NEM, but not for its stimulation by APMA and BzATP. Taken together, these results demonstrate that influx of extracellular Ca 2ϩ is sufficient to activate ADAM10 but not required for its activation.
DISCUSSION
ADAM10 is required for the proteolytic release of several cell surface proteins with important roles in development and diseases such as Alzheimer's and allergic responses, yet much remains to be learned about how ADAM10-dependent protein ectodomain shedding is regulated. Our results demonstrate that the cytoplasmic domain of ADAM10 functions as a negative regulator of the constitutive activity of ADAM10 but is dispensable for the rapid post-translational stimulation of this enzyme. The cytoplasmic domain of ADAM10 is known to contain an ER retention motif and basolateral sorting signals in polarized epithelial cells (20, 26) . We found that deletion of the ER retention motif or a point mutation in this motif both had the same effect as deleting the cytoplasmic domain altogether. Both mutants have been shown to traffic to the cell surface more efficiently (20) , and we provide evidence that this is also the case for the ADAM10⌬cyto protein. The lack of an ER retention motif also explains our finding that the levels of pro-ADAM10⌬cyto are lower than those of pro-ADAM10 WT, despite transfection with comparable amounts of expression vector for either form. Thus, the increased sheddase activity of ADAM10⌬cyto and the two mutants that affect the ER retention motif compared with the ADAM10 WT indicates that the intracellular domain of ADAM10 functions as a negative regulator of its constitutive sheddase activity by limiting the exit of ADAM10 from the ER. Targeting this ER retention motif could thus represent an attractive means to modulate the activity of ADAM10, which has been shown to function as a protective ␣-secretase in the context of Alzheimer's disease (27) (28) (29) (30) .
The observation that the cytoplasmic domain of ADAM10 is not required for stimulation of ADAM10-dependent shedding of BTC-AP shows for the first time that ADAM10 resembles the related metalloprotease ADAM17 in that a mutant form of ADAM17 lacking its cytoplasmic domain can be activated as efficiently as wild type ADAM17 by various stimulators of ectodomain shedding (11, 31, 32) . Taken together, these results also help explain the previously reported observation that there is less stimulated shedding of BTC and EGF in Adam10 Ϫ/Ϫ cells rescued with ADAM10⌬cyto compared with cells rescued with ADAM10 WT (8) . The increased constitutive activity of ADAM10⌬cyto most likely depleted the membrane-anchored substrate to a point where any increase in stimulated shedding was not evident, unless the cells are pretreated with MM to normalize the substrate levels at the outset of the experiment, as shown here.
Moreover, the finding that the transmembrane domain of ADAM10 is important for the ionomycin-stimulated shedding of BTC uncovers another similarity to ADAM17, which requires its transmembrane domain to respond to various stimuli of ectodomain shedding (11) . This suggested the possibility that ADAM17 is regulated through an interaction with one or more other membrane proteins, which was later corroborated by the identification of the seven-membrane-spanning iRhoms1 and 2 as crucial regulators of ADAM17-dependent shedding events (33) (34) (35) (36) . Recently an interaction of ADAM10 with tetraspanins that regulates its function and transport to the cell surface was reported (37) (38) (39) (40) . However, in preliminary studies (performed in collaboration with Drs. Michael Tomlinson and Paul Saftig), we found that overexpression of the tetraspanin Tspan15 increased the activity of the KKTT and KKT mutants to a similar degree as it did for ADAM10 WT and ADAM10⌬cyto (data not shown). Although these experiments do not rule out a functionally relevant interaction between tetraspanins and the transmembrane domain of ADAM10, it is clear that further studies will be necessary to understand the mechanism responsible for regulating the stimulation of ADAM10 through its transmembrane domain. Interestingly, the constitutive and ionomycin-stimulated shedding of CD62-L and TGF␣, two substrates of ADAM17 that are only shed by ADAM10 in cells lacking ADAM17 (9), still occurred in cells expressing the KKTT or KKT chimeras and was similar to the shedding seen in ADAM10⌬cyto-expressing cells. Thus, the transmembrane domain of ADAM10 appears to have a role in the ionomycin-stimulated shedding of the ADAM10 substrate BTC, but not in the constitutive or ionomycin-stimulated shedding of the ADAM17 substrates CD62-L and TGF␣, suggesting that the transmembrane domain of ADAM10 also has a role in determining its substrate selectivity.
When the cytoplasmic domain of ADAM17 was replaced with that of ADAM10, this did not detectably reduce ADAM17-dependent shedding compared with full-length ADAM17 or ADAM17 lacking its cytoplasmic domain. Thus, the negative regulatory effect of the cytoplasmic domain of ADAM10 on its constitutive shedding activity does not appear to affect ADAM17 under these conditions. On the other hand, when the extracellular domain of ADAM17 was attached to the transmembrane domain of ADAM10 or to the transmembrane domain and cytoplasmic domain of ADAM10, then all PMAstimulated activity of ADAM17 was abolished, although constitutive activity was not affected. These results are consistent with a model in which the transmembrane domain of ADAM17 is important for its activation by various stimuli, most likely because of its interaction with iRhoms (34, 35) .
The experiments addressing the role of PCs as regulators of ADAM10 argue against a major role for PCs in the stimulation of ADAM10-dependent shedding, although longer incubation with the PC inhibitor should eventually lead to depletion of mature ADAM10 and loss of its constitutive activity (23) . Similar findings have been reported for ADAM17, which does not require processing by PCs for its rapid activation by various signaling pathways (11) . Additional information on the regulation of ADAM10 is provided by our observation that its activation by IO is regulated by an influx of extracellular Ca 2ϩ ions and not by Na ϩ , K ϩ , or Cl Ϫ fluxes. However, extracellular Ca 2ϩ is not absolutely required for the activation of ADAM10, at least by APMA and BzATP.
Taken together, our findings demonstrate that the constitutive activity of ADAM10 is negatively regulated by an ER retention motif in its cytoplasmic domain. We also show that the transmembrane domain of ADAM10 is required for stimulation of ADAM10-dependent shedding of BTC, whereas the cytoplasmic domain is not. Moreover, we show that proprotein convertases or influx of extracellular Ca 2ϩ are not required for the rapid activation of ADAM10, although influx of extracellular Ca 2ϩ can activate ADAM10. Further studies will be necessary to explore how the transmembrane domain of ADAM10 controls stimulated ADAM10-dependent processing events.
